1 Del. Admin. Code § 102-7.0 - Re-Disclosure Requirements
7.1 DHIN may issue public reports containing or based upon de-identified data without Committee review and approval.
7.2 Any other re-disclosure of Available Clinical Data shall require Committee review and approval.
7.3 All Available Clinical Data that is shared publicly or re-disclosed to anyone other than an Approved User shall adhere to federal Centers for Medicare & Medicaid Services ("CMS") cell size suppression requirements for CMS Research Identifiable Files.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.